Contraline Inc.
Contraline is a Charlottesville-based company working at the forefront of reproductive medicine.
CORE INFO
Contraline Inc. is a biotechnology company focused on developing innovative male contraceptive solutions, including a topical gel and a non-hormonal implant, aimed at providing safe and reversible options for men and couples.
- Contraline recently secured $92.5 million in Series B funding, co-led by BVF Partners L.P. and RA Capital Management, to advance its NES/T Gel into late-stage development.biospace.com
- BioSpace reported on Contraline's Series B funding, highlighting its significance in advancing the NES/T Gel, a male contraceptive, into late-stage development.biospace.com
WHY WE WOULD WORK AT CONTRALINE INC.
Innovative Mission
Join a team dedicated to expanding reproductive choices for men and couples worldwide through groundbreaking male contraceptive solutions like NES/T Gel and ADAM.
Cutting-Edge Technology
Work with advanced biotechnology in developing novel male contraceptives that prioritize safety, effectiveness, and reversibility, setting new standards in reproductive health.
Growth Opportunities
Be part of a rapidly growing company that has expanded from 7 to 27 employees, with significant funding to propel your career forward in a dynamic environment.
Competitive Compensation
Benefit from a robust funding history, including $92.5 million in Series B financing, ensuring competitive salaries and resources for employee development.
Impactful Work
Contribute to meaningful clinical advancements, such as the successful Phase 2b trial of NES/T Gel, making a real difference in the lives of couples seeking contraceptive options.
Collaborative Culture
Join a passionate team of experts in biotechnology, fostering a collaborative environment that values innovation and encourages diverse perspectives in problem-solving.
MARKET AND TRACTION
TOTAL ADDRESSABLE MARKET
KEY METRICS
✦ KEY METRICGROWTH TACTICS
COMPETITIVE ADVANTAGE
MARKET POSITION
PRODUCT AND TECH
NES/T Gel
NES/T Gel is a once-daily topical gel that combines a synthetic progestin with testosterone to effectively suppress sperm production while maintaining normal testosterone levels. This innovative male contraceptive solution aims to provide a safe, effective, and reversible option for men.
ADAM Implant
The ADAM implant is a long-lasting, non-hormonal contraceptive device designed to block sperm in the vas deferens without affecting sensation or ejaculation. This technology represents a significant advancement in male contraception, offering a reversible solution that enhances reproductive choices for men.
Clinical Development
Contraline is focused on advancing its products through rigorous clinical testing, including the successful completion of a Phase 2b trial for NES/T Gel. This commitment to clinical development ensures that their contraceptive solutions are both effective and acceptable to users.
Biotechnology Innovations
As a clinical-stage biotechnology company, Contraline leverages cutting-edge research and technology to develop novel male contraceptive solutions. Their focus on innovation in reproductive health aims to expand the options available for family planning.
Funding for Advancement
Contraline has raised approximately $113.98 million in funding, including a recent $92.5 million Series B round, to support the late-stage development of NES/T Gel and other products. This financial backing is crucial for bringing their innovative contraceptive solutions to market.